SNCA and Parkinson disease: If this mechanism also occurs in human patients, the interaction of ɑ-synuclein with microglia, as opposed to its accumulation in dopaminergic neurons, may be a key component of the initial immune response driving degeneration of the dopaminergic system in PD.